A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Rabino’s journey from a medical professional to an advocate for women’s health is a testament to both her resilience and her ...

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

The outcomes of this trial help confirm that cisplatin chemotherapy given adjuvantly with radiotherapy is not a superior alternative ,” said Sang Young Ryu, MD.

Genmab has announced that the European Commission (EC) has approved Tivdak (tisotumab vedotin) to treat recurrent or ...

the first ADC for cervical cancer, after Phase 3 trial shows a 30% reduction in death risk vs. chemotherapy. The trial of 502 patients showed Tivdak improved median overall survival to 11.5 months vs.

Ending the silent epidemic: Ravneet Kaur & Dr. Syama B Syam Wednesday, March 26, 2025, 08:00 Hrs [IST] Cervical cancer remains a serious health ...